1. Melatonin for non-respiratory sleep disorders in typically developing children
- Author
-
Carolyn Dakin, Helen Heussler, Sohil Khan, David Pache, Vicki Flenady, David M. Cooper, Treasure McGuire, Bruce G. Charles, and Ross Norris
- Subjects
Medicine General & Introductory Medical Sciences ,medicine.medical_specialty ,Sleep disorder ,business.industry ,education ,medicine.disease ,Sleep in non-human animals ,Sleep medicine ,Melatonin ,03 medical and health sciences ,Typically developing ,0302 clinical medicine ,Editorial team ,030225 pediatrics ,medicine ,Physical therapy ,Pharmacology (medical) ,Psychiatry ,business ,Psychosocial ,030217 neurology & neurosurgery ,medicine.drug - Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of melatonin for non‐respiratory sleep disorders in typically developing children, with regard to improvement in sleep initiation, sleep maintenance and sleep scheduling, when compared with placebo, other medication for sleep disorders, psychological/behavioural therapy, light therapy or no treatment.
- Published
- 2017
- Full Text
- View/download PDF